Publications

Select publications 

For more publications, please view the member profiles.

• Mogasale VV, John J, Sahai N, Ray A, Farooqui HH, Mogasale V, Dhoubhadel BG, Edmunds WJ, Clark A, Abbas K. Burden of typhoid fever and antimicrobial resistance in India (2023): a modelling study. Lancet Regional Health Southeast Asia, 44:100714, 2026. https://doi.org/10.1016/j.lansea.2025.100714 

• Kang H, Lim A, Clark A, Colón González FJ, Clapham HE, Carrera J, Kim J, Auzenbergs M, Lakshminarayanan P, López-Vergès S, Sim SY, Han SM, Cerqueira-Silva T, Endy T, Cucunubá ZM, Edmunds WJ, Sahastrabuddhe S, Brady OJ, Abbas K. Age-specific chikungunya outbreak response immunisation strategies in Brazil: a modelling study. EClinicalMedicine, 90:103690, 2025. https://doi.org/10.1016/j.eclinm.2025.103690 

• Kim S, Kang H, Skrip L, Sahastrabuddhe S, Islam A, Jung SM, Vesga JF, Endo A, Edmunds WJ, Abbas K. Progress and challenges in Nipah vaccine development and licensure for epidemic preparedness and response. Expert Review of Vaccines, 24(1):183-193, 2025. https://doi.org/10.1080/14760584.2025.2476523 

• Anwari P, Burnett E, Chavers TP, Samsor A, Safi H, Safi N, Clark AD, Parashar UD, Tate JE. Post-marketing surveillance of intussusception after Rotarix administration in Afghanistan, 2018-2022. Vaccine, 42(8):2059-2064, 2024. https://doi.org/10.1016/j.vaccine.2024.02.057   

• Mogasale VV, Sinha A, John J, Hasan Farooqui H, Ray A, Chantler T, Mogasale V, Dhoubhadel BG, Edmunds WJ, Clark A, Abbas K. Research priorities to support typhoid conjugate vaccine decision-making in India: evidence assessment and stakeholder survey. BMJ Public Health, 2(2):e001089, 2024. https://doi.org/10.1136/bmjph-2024-001089

• Kang H, Auzenbergs M, Clapham H, Maure C, Kim JH, Salje H, Taylor CG, Lim A, Clark A, Edmunds WJ, Sahastrabuddhe S, Brady OJ, Abbas K. Chikungunya seroprevalence, force of infection, and prevalence of chronic disability after infection in endemic and epidemic settings: a systematic review, meta-analysis, and modelling study. The Lancet Infectious Diseases, S1473-3099(23)00810-1, 2024. https://doi.org/10.1016/S1473-3099(23)00810-1    

• Giannini F, Cannon JW, Cadarette D, Bloom DE, Moore HC, Carapetis J, Abbas K. Modeling the potential health impact of prospective Strep A vaccines. NPJ Vaccines, 8(1):90, 2023. https://doi.org/10.1038/s41541-023-00668-0   

• Kim C, Holm M, Frost I, Hasso-Agopsowicz M, Abbas K. Global and regional burden of attributable and associated bacterial antimicrobial resistance avertable by vaccination: modelling study. BMJ Global Health, 8(7):e011341, 2023. https://doi.org/10.1136/bmjgh-2022-011341  

• Kobayashi T, Tomoi H, Nishina Y, Harada K, Tanaka K, Sasaki S, Inaba K, Mitaka H, Takahashi H, Passanante A, Lau EHY, Naito T, Larson H, Wu J, Lin L, Yamada Y. Effect of a mobile app chatbot and an interactive small-group webinar on COVID-19 vaccine intention and confidence in Japan: a randomised controlled trial. BMJ Global Health, 8(5):e010370, 2023. https://doi.org/10.1136/bmjgh-2022-010370  

• Khongyot T, Moriyasu T. Invasive Pneumococcal Disease diminish during the onset of COVID-19 in Japan between 2019 and 2022. International Journal of Infectious Diseases, 122:307-309, 2022. https://doi.org/10.1016/j.ijid.2022.05.064